🔴 Altimmune is trading 5% down today as biotech shares face pressure

Altimmune is trading at $2.24, down -5.08%, amid broader biotech weakness.

• No new company-specific catalyst was detected for Altimmune on October 16; available reporting describes biotech shares as under pressure.
• The provided sector context shows XBI down 2.06% during the regular session.
• Market-wide selling and risk aversion may also be weighing on shares, but there is no clear company-specific explanation.